Your browser doesn't support javascript.
loading
Collider bias undermines our understanding of COVID-19 disease risk and severity
Gareth Griffith; Tim T Morris; Matt Tudball; Annie Herbert; Giulia Mancano; Lindsey Pike; Gemma C Sharp; Tom M Palmer; George Davey Smith; Kate Tilling; Luisa Zuccolo; Neil M Davies; Gibran Hemani.
Afiliación
  • Gareth Griffith; MRC Integrative Epidemiology Unit, University of Bristol
  • Tim T Morris; University of Bristol
  • Matt Tudball; MRC Integrative Epidemiology Unit, University of Bristol
  • Annie Herbert; University of Bristol
  • Giulia Mancano; University of Bristol
  • Lindsey Pike; University of Bristol
  • Gemma C Sharp; University of Bristol
  • Tom M Palmer; University of Bristol
  • George Davey Smith; University of Bristol
  • Kate Tilling; University of Bristol
  • Luisa Zuccolo; University of Bristol
  • Neil M Davies; University of Bristol
  • Gibran Hemani; University of Bristol
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-20090506
ABSTRACT
Observational data on COVID-19 including hypothesised risk factors for infection and progression are accruing rapidly, often from non-random sampling such as hospital admissions, targeted testing or voluntary participation. Here, we highlight the challenge of interpreting observational evidence from such samples of the population, which may be affected by collider bias. We illustrate these issues using data from the UK Biobank in which individuals tested for COVID-19 are highly selected for a wide range of genetic, behavioural, cardiovascular, demographic, and anthropometric traits. We discuss the sampling mechanisms that leave aetiological studies of COVID-19 infection and progression particularly susceptible to collider bias. We also describe several tools and strategies that could help mitigate the effects of collider bias in extant studies of COVID-19 and make available a web app for performing sensitivity analyses. While bias due to non-random sampling should be explored in existing studies, the optimal way to mitigate the problem is to use appropriate sampling strategies at the study design stage.
Licencia
cc_by
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Rct Idioma: En Año: 2020 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Rct Idioma: En Año: 2020 Tipo del documento: Preprint